title: When to stop a clinical trial early for benefit: lessons learned and future approaches.
authors.affiliation: INSERM, Centre d'Investigation Clinique 9501 and Unité 961, Centre Hospitalier Universitaire, and the Department of Cardiology, Nancy University, Nancy, France. f.zannad@chu-nancy.fr
authors.forename: Faiez
authors.initials: F
authors.lastname: Zannad
authors.forename: Wendy
authors.initials: W
authors.lastname: Gattis Stough
authors.forename: John J V
authors.initials: JJ
authors.lastname: McMurray
authors.forename: Willem J
authors.initials: WJ
authors.lastname: Remme
authors.forename: Bertram
authors.initials: B
authors.lastname: Pitt
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Borer
authors.forename: Nancy L
authors.initials: NL
authors.lastname: Geller
authors.forename: Stuart J
authors.initials: SJ
authors.lastname: Pocock
mesh_terms: D002986:Clinical Trials as Topic; D003657:Decision Making; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D013997:Time Factors; D028761:Withholding Treatment / Q000592:standards*